Kezar Life Sciences Inc (KZR)

$7.11 0.20 (2.74%)
16:00 EST KZR Stock Quote Delayed 30 Minutes

Kezar Life Sciences (KZR) Stock Soars on Lupus Trial Results

Shares of Kezar Life Sciences are up an astounding 74% today after the biotechnology company reported positive results from its clinical trial regarding a treatment for the autoimmune disease Lupus.

Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Tuesday

Billionaire Israel Englander Is Betting Big on These 5 Stocks

3 Biotech Stocks to Buy Before They Boom

More Articles
Select Price, Percent change, or Dollar change as the y-axis.
Select Area, Line, OHLC or Candlestick as the chart type.
Previous Close -
Market Cap 486.17M
PE Ratio -6.97
EPS -1.02
Volume (Avg. Vol.) 432,637
Day's Range $7.07 - $7.44
52-Week Range $4.31 - $18.55
Dividend & Yield N/A (N/A)